Testing version — LOERadar is in active testing. Features and data may change.
TAMIFLU (OSELTAMIVIR PHOSPHATE) | LOERadar
TAMIFLU
NDA
OSELTAMIVIR PHOSPHATE | N021246 | HOFFMANN LA ROCHE INC
2 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — EQ 12MG BASE/ML
0 patents0 exclusivities▴
FOR SUSPENSION;ORAL | Approved: Dec 14, 2000
No patent or exclusivity listings for this strength.